Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Mersen Pharmaceutical Technology Development is a specialized biotechnology company headquartered in Beijing, China, focusing on advanced drug delivery systems. Established in 2004, the company has built a robust reputation for its expertise in long-acting injectable formulations, particularly microspheres and liposomes. Mersen operates as a high-tech enterprise providing research, development, and technology transfer services to the pharmaceutical industry. Their technology platform is designed to enhance the therapeutic efficacy and patient compliance of peptides and small molecules in areas such as endocrinology and oncology. The company maintains state-of-the-art facilities for formulation optimization and pilot-scale production. By bridging the gap between laboratory research and industrial manufacturing, Mersen supports the commercialization of complex generic and innovative drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Mersen Pharmaceutical Technology Development.